This Is MS Multiple Sclerosis Community: Knowledge & Support

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058757/

What does, "IR does not control the patients, so they often do not control the trials" mean? Patients are sent by primary doctors to IRs for one-time treatment, and then go back to the primary doctors for future care? In CCSVI, this is where we might see neurologist-controlled trials? Because the neurologists control us as MS patients...

The next two reasons have to do with funding. The device manufacturers don't need to fund a trial because there's no requirement that they do before the device gets approved for use. The IR market is small -- does 600,000 people with MS in the US change that or is that still small? -- and so the industry is not willing to invest large sums.

How did other researchers wanting to do interventional radiology randomized controlled trials overcome these obstacles? The link above discusses an ASTRAL trial about renal artery stenting. Where did their funding come from?

Maybe they applied for and received a grant from somewhere?

Grants would be helpful!
Here's an interventional radiology study called PIVOT that received $10 million from the National Institutes of Health’s National Heart, Lung and Blood Institute (NHLBI). http://www.sirweb.org/news/newsPDF/ATTRACT.pdf

Here are SIR foundation grants: http://www.sirfoundation.org/grants-awards/

Here's a renal denervation study funded by the catheter and specific generator manufacturer: http://esciencenews.com/articles/2011/0 ... sults.last

Basically we need NIH and their $10 million.

Sources of funding for the PREMiSe trial.